T-cell prolymphocytic leukaemia associated with immune checkpoint inhibitor (pembrolizumab)
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2021-245603
Abstract: We describe the case of a man in his 60s with squamous cell carcinoma of the lung with brain metastasis treated with pembrolizumab who subsequently developed T-cell prolymphocytic leukaemia. He was transferred to our hospital… read more here.
Keywords: cell; immune checkpoint; checkpoint; cell prolymphocytic ... See more keywords
Comparison of karyotyping, TCL1 fluorescence in situ hybridisation and TCL1 immunohistochemistry in T cell prolymphocytic leukaemia
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Pathology"
DOI: 10.1136/jclinpath-2017-204616
Abstract: Aims T cell prolymphocytic leukaemia (T-PLL) is defined as an aggressive T cell leukaemia composed of small to medium-sized lymphocytes with a mature T cell immunophenotype. Most of these cases are known to be associated… read more here.
Keywords: tcl1 rearrangement; prolymphocytic leukaemia; tcl1; cell prolymphocytic ... See more keywords